EUVIMEDEUVIMED entdecken
Crossref

Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma

Shawn A. Abeynaike, Roberta Vezza Alexander, Christina A. Snider, In Hwan Park, Shumei Kato, Razelle Kurzrock, Diana C. Hargreaves, Karen S. Messer, Gregory P. Botta

JCO Oncology Advances · 2026-07 · 3 (3)

DOI: 10.1200/oa-26-00074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Advances, 2026-07. Verfasst von Shawn A. Abeynaike und 8 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abeynaike, S. A., Alexander, R. V., Snider, C. A., Park, I. H., Kato, S., Kurzrock, R., Hargreaves, D. C., Messer, K. S., & Botta, G. P. (2026). Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma. JCO Oncology Advances, 3(3). https://doi.org/10.1200/oa-26-00074

Vancouver

Abeynaike SA, Alexander RV, Snider CA, Park IH, Kato S, Kurzrock R, et al. Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma. JCO Oncology Advances. 2026;3(3). doi:10.1200/oa-26-00074

BibTeX
@article{Abeynaike2026,
  author = {Abeynaike, Shawn A. and Alexander, Roberta Vezza and Snider, Christina A. and Park, In Hwan and Kato, Shumei and Kurzrock, Razelle and Hargreaves, Diana C. and Messer, Karen S. and Botta, Gregory P.},
  title = {Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma},
  journal = {JCO Oncology Advances},
  year = {2026},
  volume = {3},
  number = {3},
  doi = {10.1200/oa-26-00074}
}
Kostenlos starten →